4th Nov 2024 07:00
| ||||||||
| Notes | Sep. 30, 2024 |
| Dec. 31, 2023 | ||||
|
| |||||||
Assets |
|
|
| |||||
Cash and balances at the central bank | 9 | 94,568,773 |
| 71,887,821 | ||||
Due from banks | 10 | 305,235,726 |
| 231,085,244 | ||||
Loans and advances to banks, net | 12 | 3,323,215 |
| 822,448 | ||||
Loans and advances to customers, net | 13 | 304,043,669 |
| 234,985,936 | ||||
Derivative financial instruments | 1,769,619 |
| 1,105,148 | |||||
Financial investments |
|
|
| |||||
- Financial Assets at Fair Value through P&L | 14 | 2,066,889 |
| - | ||||
- Financial Assets at Fair Value through OCI | 14 | 223,821,557 |
| 233,125,234 | ||||
- Financial Assets at Amortized cost | 14 | 145,437,207 |
| 38,341,019 | ||||
- Investments in associates | 15 | 107,446 |
| 115,979 | ||||
Non current assets held for sale | 30.1 | - |
| 161 | ||||
Other assets | 16 | 34,331,134 |
| 18,972,786 | ||||
Deferred tax assets | 2,135,720 |
| 1,685,231 | |||||
Property and equipment | 17 | 3,117,062 |
| 2,739,092 | ||||
Total assets |
| 1,119,958,017 |
| 834,866,099 | ||||
Liabilities and equity |
|
|
| |||||
Liabilities |
|
|
| |||||
Due to banks | 18 | 3,799,980 |
| 12,458,003 | ||||
Due to customers | 19 | 900,966,962 |
| 677,237,479 | ||||
Non current liabilities held for sale | 30.2 | 1,327 |
| 873 | ||||
Derivative financial instruments | 138,896 |
| 140,934 | |||||
Current income tax liabilities | 14,269,506 |
| 9,395,534 | |||||
Other liabilities | 20 | 21,760,126 |
| 18,339,465 | ||||
Issued debt instruments | 21 | 4,811,742 |
| 3,073,349 | ||||
Other loans | 20,324,693 |
| 12,483,907 | |||||
Other provisions | 22 | 15,478,489 |
| 11,095,089 | ||||
Total liabilities |
| 981,551,721 |
| 744,224,633 | ||||
Equity |
|
|
| |||||
Issued and paid up capital | 30,431,580 |
| 30,195,010 | |||||
Reserves | 62,260,417 |
| 28,807,042 | |||||
Reserve for employee stock ownership plan (ESOP) | 1,667,230 |
| 1,486,010 | |||||
Retained earnings * | 43,924,408 |
| 29,993,331 | |||||
Total equity and net profit for the period / year |
| 138,283,635 |
| 90,481,393 | ||||
Non Controlling Interest | 122,661 |
| 160,073 | |||||
Total minority interest, equity and net profit for the period / year | 138,406,296 |
| 90,641,466 | |||||
Total liabilities and equity |
| 1,119,958,017 |
| 834,866,099 |
Condensed Consolidated Interim Income Statement for the period ended September 30, 2024 | ||||||
| Last 9 Months |
| Last 9 Months | |||
Notes |
| Sep. 30, 2024 |
| Sep. 30, 2023 | ||
|
| |||||
Interest and similar income | 130,999,623 |
| 73,006,422 | |||
Interest and similar expense | (65,316,717) |
| (35,275,583) | |||
Net interest income |
|
| 65,682,906 |
| 37,730,839 | |
|
| |||||
Fee and commission income | 9,274,284 |
| 6,543,585 | |||
Fee and commission expense | (4,049,111) |
| (2,589,680) | |||
Net fee and commission income |
|
| 5,225,173 |
| 3,953,905 | |
|
| |||||
Dividend income | 70,934 |
| 83,653 | |||
Net trading income | 6 | 18,194,491 |
| 3,165,144 | ||
Profits (Losses) on financial investments | 14.1 | 377,992 |
| 165,478 | ||
Administrative expenses | (9,180,646) |
| (6,501,663) | |||
Other operating income (expenses) | 7 | (17,995,808) |
| (5,679,447) | ||
Goodwill amortization | - |
| (30,943) | |||
Intangible assets amortization | - |
| (24,188) | |||
Impairment release (charges) for credit losses |
| (3,745,003) |
| (1,216,770) | ||
Bank's share in the profits / losses of associates | (8,533) |
| (39,486) | |||
Profit before income tax |
| 58,621,506 |
| 31,606,522 | ||
|
| |||||
Income tax expense | 29 | (17,207,903) |
| (9,540,412) | ||
Deferred tax assets (Liabilities) | 29 |
| 934,295 |
| 392,680 | |
Net profit from continued operations |
|
| 42,347,898 |
| 22,458,790 | |
|
|
| ||||
Discontinued Operations |
|
|
|
| ||
Net profit (loss) from discontinued operations | 30.3 | - |
| (49,699) | ||
Net profit for the period |
|
| 42,347,898 |
| 22,409,091 | |
|
|
| ||||
Non Controlling Interest |
| (45) |
| 3,328 | ||
Bank's shareholders |
|
| 42,347,943 |
| 22,405,763 | |
|
|
| ||||
Earnings per share | 8 |
|
|
| ||
Basic |
| 12.42 |
| 6.41 | ||
Diluted |
| 12.26 |
| 6.33 | ||
Islam Zekry |
| Hisham Ezz Al-Arab | ||||
Group CFO |
| Chairman |
Condensed Consolidated Interim statement of Comprehensive Income for the period ended September 30, 2024 | ||||
| Last 9 Months | Last 9 Months | ||
| Sep. 30, 2024 |
| Sep. 30, 2023 | |
|
|
| ||
Net profit for the period |
| 42,347,898 |
| 22,409,091 |
|
|
| ||
Transferred to RE from financial assets at fair value through comprehensive income |
| (370,224) |
| (95,308) |
Change in fair value of Financial investments measured at fair value through comprehensive income after tax |
| 8,272,930 |
| (9,629,911) |
Cumulative foreign currencies translation differences |
| 883,684 |
| 193,162 |
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income |
| 623,199 |
| 201,185 |
Total comprehensive income for the period |
| 51,757,487 |
| 13,078,219 |
As follows: |
| |||
Bank's shareholders |
| 51,757,532 |
| 13,074,891 |
Non Controlling Interest |
| (45) |
| 3,328 |
Total comprehensive income for the period |
| 51,757,487 |
| 13,078,219 |
Condensed Consolidated Interim Cash flows for the period ended September 30, 2024 | ||||
| ||||
Notes | Sep. 30, 2024 |
| Sep. 30, 2023 | |
|
| |||
Cash flow from operating activities |
|
|
| |
Profit before income tax from continued operations | 58,621,506 |
| 31,606,522 | |
Profit (loss) from discontinued operations | - |
| (49,699) | |
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
| |
Fixed assets depreciation | 17 | 763,079 |
| 655,051 |
Impairment Release/charge for credit losses (Loans and advances to customers and banks) | 4,224,251 |
| 1,050,980 | |
Other provisions Release/charge | 22 | 430,005 |
| 2,350,253 |
Impairment Release/charge for credit losses (due from banks) | 829 |
| (47,249) | |
Impairment Release/charge for credit losses (financial investments) | (480,077) |
| 213,039 | |
Impairment Release/charge for other assets | (11,956) |
| 14,347 | |
Exchange revaluation differences for financial assets at fair value through OCI and AC | (18,536,183) |
| (5,409,592) | |
Goodwill amortization | - |
| 30,943 | |
Intangible assets amortization | - |
| 24,188 | |
Revaluation differences Impairment charge for Financial Assets at Fair value through OCI | 1,193,810 |
| - | |
Revaluation differences Impairment charge for Financial Assets at Amortized cost | 107,207 |
| - | |
Revaluation differences Impairment charge for due from banks | 1,308 |
| - | |
Utilization of other provisions | 22 | (9,196) |
| (1,608) |
Exchange Revaluation differences of other provisions | 22 | 3,962,591 |
| 1,096,665 |
Profits/losses from selling property and equipment | 7 | (2,254) |
| (194) |
Profits/losses from selling financial investments at fair value through OCI | 14.1 | (377,992) |
| (149,012) |
Losses (Profits) from selling investments in associates | - |
| (7,466) | |
Impairment (Released) charges of investments in associates | - |
| (9,000) | |
Share based payments | 804,345 |
| 608,250 | |
Bank's share in the profits / losses of associates | 8,533 |
| 39,486 | |
Operating profits before changes in operating assets and liabilities |
| 50,699,806 |
| 32,015,904 |
|
| |||
Net decrease / increase in assets and liabilities |
|
|
| |
Due from banks | (14,547,420) |
| 9,859,636 | |
Financial assets at fair value through P&L | (2,066,889) |
| - | |
Derivative financial instruments | (225,875) |
| 172,635 | |
Loans and advances to banks and customers | 12 - 13 | (75,774,541) |
| (27,548,758) |
Other assets | (14,094,581) |
| (2,506,019) | |
Non current assets held for sale | - |
| (214) | |
Due to banks | 18 | (8,658,023) |
| 15,526,008 |
Due to customers | 19 | 223,729,483 |
| 136,052,663 |
Current income tax obligations paid | (2,938,397) |
| (2,546,958) | |
Non current liabilities held for sale | 1,327 |
| 933 | |
Other liabilities | (5,488,554) |
| (3,890,097) | |
Net cash generated from (used in) operating activities |
| 150,636,336 |
| 157,135,733 |
|
| |||
Cash flow from investing activities |
|
|
| |
Proceeds from sale of investments in associates | 11,956 |
| 2,119 | |
Payments for purchases of property, equipment and branches construction | (2,401,070) |
| (1,177,450) | |
Proceeds from selling property and equipment | 2,254 |
| 194 | |
Proceeds from redemption of financial assets at amortized cost | 1,226,638 |
| 5,278,030 | |
Payments for purchases of financial assets at amortized cost | (106,105,142) |
| (9,334,085) | |
Payments for purchases of financial assets at fair value through OCI | (22,138,419) |
| (64,860,157) | |
Proceeds from selling financial assets at fair value through OCI | 55,475,567 |
| 75,128,566 | |
Payment for investment in subsidiaries | - |
| (1,008,761) | |
Net cash generated from (used in) investing activities |
| (73,928,216) |
| 4,028,456 |
Condensed Consolidated Interim Cash flows for the period ended September 30, 2024 (Cont.) | ||||
| ||||
Sep. 30, 2024 |
| Sep. 30, 2023 | ||
|
| |||
Cash flow from financing activities |
|
|
| |
Other loans | 7,840,786 |
| 2,408,739 | |
Dividends paid | (5,116,159) |
| (3,594,747) | |
Issued debt instruments | 1,738,393 |
| 615,227 | |
Capital increase | 236,570 |
| 369,876 | |
Net cash generated from (used in) financing activities |
| 4,699,590 |
| (200,905) |
|
| |||
Net (decrease) increase in cash and cash equivalent during the period | 81,407,710 |
| 160,963,284 | |
Beginning balance of cash and cash equivalent | 234,317,913 |
| 92,969,526 | |
Cash and cash equivalent at the end of the period |
| 315,725,623 |
| 253,932,810 |
|
| |||
Cash and cash equivalent comprise: |
|
|
| |
Cash and balances at the central bank | 9 | 94,568,773 |
| 59,950,223 |
Due from banks | 305,240,021 |
| 276,845,003 | |
Treasury bills and other governmental notes | 11 | 82,174,775 |
| 71,507,826 |
Obligatory reserve balance with CBE | (76,360,420) |
| (52,963,236) | |
Due from banks with maturity more than three months | (19,125,420) |
| (30,994,611) | |
Treasury bills and other governmental notes with maturity more than three months | (70,772,106) |
| (70,412,395) | |
Total cash and cash equivalent |
| 315,725,623 |
| 253,932,810 |
Condensed Consolidated Interim statement of changes in shareholders' equity |
| |||||||||||||
Sep. 30, 2023 | Issued and paid up capital | Legal reserve | General reserve | General risk reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders Equity | Non Controlling Interest | Total |
Beginning balance | 29,825,134 | 3,963,946 | 27,096,858 | 1,550,906 | 8,183 | 18,947 | (13,188,818) | 11,981 | 16,393,841 | 1,895,435 | 181,324 | 67,757,737 | 580,431 | 68,338,168 |
Capital increase | 369,876 | - | - | - | - | - | - | - | - | - | - | 369,876 | - | 369,876 |
Reserve for transactions under common control | - | - | - | - | (679,155) | - | - | - | - | - | - | (679,155) | - | (679,155) |
Transferred to reserves | - | 806,408 | 12,743,849 | - | - | 2,208 | - | - | (12,388,223) | (1,164,242) | - | - | - | - |
Net profit for the period | - | - | - | - | - | - | - | - | 22,405,763 | - | - | 22,405,763 | 3,328 | 22,409,091 |
Dividends paid | - | - | - | - | - | - | - | - | (3,738,888) | - | - | (3,738,888) | (17,108) | (3,755,996) |
Change in non controlling interest from acquisition of subsidiaries | - | - | - | - | - | - | - | - | - | - | - | - | (536,867) | (536,867) |
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | (95,308) | - | 95,308 | - | - | - | - | - |
Net unrealized gain/(loss) on financial assets at fair value through OCI after tax | - | - | - | - | - | - | (9,629,911) | - | - | - | - | (9,629,911) | - | (9,629,911) |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | 3,249 | (3,249) | - | - | - | - | - |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | 201,185 | - | - | - | - | 201,185 | - | 201,185 |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 608,250 | - | 608,250 | - | 608,250 |
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | 11,838 | 11,838 | 99,192 | 111,030 |
Ending balance | 30,195,010 | 4,770,354 | 39,840,707 | 1,550,906 | (670,972) | 21,155 | (22,712,852) | 15,230 | 22,764,552 | 1,339,443 | 193,162 | 77,306,695 | 128,976 | 77,435,671 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sep. 30, 2024 | Issued and paid up capital | Legal reserve | General reserve | General risk reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders Equity | Non Controlling Interest | Total |
Beginning balance | 30,195,010 | 4,770,354 | 39,840,707 | 1,550,906 | (670,972) | 21,155 | (16,868,691) | 15,230 | 29,993,331 | 1,486,010 | 148,353 | 90,481,393 | 160,073 | 90,641,466 |
Capital increase | 236,570 | - | - | - | - | - | - | - | - | - | - | 236,570 | - | 236,570 |
Transferred to reserves | - | 1,438,320 | 22,582,085 | - | - | 1,663 | - | - | (23,398,943) | (623,125) | - | - | - | - |
Dividends paid | - | - | - | - | - | - | - | - | (5,366,429) | - | - | (5,366,429) | (37,367) | (5,403,796) |
Net profit for the period | - | - | - | - | - | - | - | - | 42,347,943 | - | - | 42,347,943 | (45) | 42,347,898 |
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | (370,224) | - | 370,224 | - | - | - | - | - |
Change in non controlling interest from acquisition of subsidiaries | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Transferred from RE to banking risk reserve | - | - | - | - | - | - | - | 19,024 | (19,024) | - | - | - | - | - |
Net unrealised gain/(loss) on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 8,272,930 | - | - | - | - | 8,272,930 | - | 8,272,930 |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | 2,694 | (2,694) | - | - | - | - | - |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | 623,199 | - | - | - | - | 623,199 | - | 623,199 |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 804,345 | - | 804,345 | - | 804,345 |
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | 883,684 | 883,684 | - | 883,684 |
Ending balance | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | (670,972) | 22,818 | (8,342,786) | 36,948 | 43,924,408 | 1,667,230 | 1,032,037 | 138,283,635 | 122,661 | 138,406,296 |
Related Shares:
Com.int.bk.regs